Respiratory disease companies develop therapies, diagnostics and research technologies for conditions affecting the lungs and airways. Their work supports earlier detection, improved disease monitoring and the development of treatments for acute, chronic and inherited pulmonary disorders.
This category includes companies working on:
Browse 67 UK respiratory disease companies below.
Global pharma company in immunology, vaccines, and oncology
GSK is a multinational biopharmaceutical company engaged in the research, development, manufacture, and commercialisation of medicines and vaccines. Its pipeline and portfolio…
Clinical-stage antifungal drug developer targeting invasive fungal infections
F2G is a clinical-stage biopharmaceutical company developing novel antifungal therapies for life-threatening invasive fungal infections. The company discovered the orotomides, a…
Surface acoustic wave nebuliser platform for inhaled drug delivery
Nebu~Flow is a UK medical technology company developing next-generation nebuliser devices using patented surface acoustic wave technology to aerosolise drugs into precisely…
CRO specialising in oncology, inflammation and respiratory disease models
Axis Bioservices is a preclinical contract research organisation providing bespoke in vitro and in vivo study services for pharmaceutical, biotechnology and academic clients.…
Transformative medicines for cystic fibrosis and serious genetic diseases
Vertex Pharmaceuticals is a global biopharmaceutical company with its European R&D headquarters at Milton Park, Oxfordshire, and its international commercial headquarters in…
UK affiliate of global family-owned biopharmaceutical company
Boehringer Ingelheim is a global family-owned biopharmaceutical company founded in 1885. Its Bracknell headquarters houses functions spanning research and development, regulatory…
Specialist CRO for inhaled and nasal drug product development
Nanopharm is a contract research organisation specialising in the development of orally inhaled and nasal drug products, providing formulation development, materials…
Specialist CRO for rare disease drug development and commercialisation
TMC Pharma Services is a contract research organisation specialising in drug development support for rare and orphan diseases. The company serves small and mid-sized biotech and…
Infectious disease drug development and partnering organisation
Infex Therapeutics is a clinical-stage drug development company focused on antimicrobial resistance and pandemic-priority infectious diseases, based at Alderley Park. Founded as…
Non-invasive deep lung breath sampling device for molecular research
PulmoBioMed is a medical technology company developing a handheld device for collecting exhaled breath condensate from the lower respiratory tract without contamination from the…
Inhaled therapies for COPD and chronic respiratory diseases
Verona Pharma is a biopharmaceutical company developing and commercialising inhaled therapies for chronic respiratory diseases. Its lead product, ensifentrine, is a first-in-class…
AI-driven T-cell receptor discovery platform for solid tumour immunotherapies
Exogene is an Oxford biotech developing TCR-based immunotherapies for solid tumours. Its platform integrates generative AI, biophysical simulation, and high-throughput TCR-antigen…